Human Immunodeficiency Virus Type 1 Group M Protease in Cameroon: Genetic Diversity and Protease Inhibitor Mutational Features

To establish a baseline for monitoring resistance to protease inhibitors (PIs) and examining the efficacy of their use among persons in Cameroon infected with human immunodeficiency virus type 1 (HIV-1), we analyzed genetic variability and PI resistance-associated substitutions in PCR-amplified prot...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Fonjungo, Peter N., Mpoudi, Eitel N., Torimiro, Judith N., Alemnji, George A., Eno, Laura T., Lyonga, Esther J., Nkengasong, John N., Lal, Renu B., Rayfield, Mark, Kalish, Marcia L., Folks, Thomas M., Pieniazek, Danuta
Format: Artigo
Sprache:Inglês
Veröffentlicht: American Society for Microbiology 2002
Schlagworte:
Virology
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC120267/
https://ncbi.nlm.nih.gov/pubmed/11880402
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JCM.40.3.837-845.2002
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge